The SOX11 Interactome Reveals the SOX11:SMARCA4 Complex As a Driver of Oncogenic Transcriptional Programs in Mantle Cell Lymphoma

被引：0
|
作者：
De Bolos, Amna [1 ,2 ]
Carreras-Caballe, Maria [1 ]
Sureda-Gomez, Marta [1 ]
Rodriguez, Marta Leonor [1 ]
Charalampopoulou, Stella [1 ]
Albero, Robert [1 ]
Maiques-Diaz, Alba [1 ]
Playa-Albinyana, Heribert [1 ,2 ,3 ]
Colomer, Dolors [1 ,2 ,3 ,4 ]
Martin-Subero, Jose Ignacio [1 ,4 ]
Campo, Elias [1 ,2 ,3 ,4 ]
Reverter, David [5 ,6 ,7 ]
Villanueva, Josep [2 ,8 ]
Amador, Virginia [1 ,2 ]
机构：
[1] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[2] Ctr Invest Biomed Red Canc CIBERONC, Barcelona, Spain
[3] Univ Barcelona UB, Barcelona, Spain
[4] Hosp Clin Barcelona, Pathol Dept, Hematopathol Sect, Barcelona, Spain
[5] Inst Catalana Recerca i Estudis Avancats ICREA, Barcelona, Spain
[6] Univ Autonoma Barcelona, Inst Biotecnol & Biomed IBB, Bellaterra, Spain
[7] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain
[8] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-200616
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1371 / 1372
页数：2
相关论文
共 50 条
  • [21] Inconsistency associated with SOX11 immunohistochemistry in mantle cell lymphoma: a meta-analysis
    Lee, Woojoo
    Shin, Eun
    Kim, Bo Hyung
    Kim, Hyunchul
    JOURNAL OF HEMATOPATHOLOGY, 2019, 12 (03) : 109 - 119
  • [22] Expression of SOX11 transcription factor. Its implication in mantle cell lymphoma
    Roisman, Alejandro
    Slavutsky, Irma
    MEDICINA-BUENOS AIRES, 2014, 74 (02) : 140 - 146
  • [23] Expression of SOX11 in mantle cell lymphoma is associated with increased angiogenesis and immunosuppressive microenvironment
    Veloza, L.
    Balsas, P.
    Ribera-Cortada, I.
    Martinez, A.
    Amador, V.
    Campo, E.
    VIRCHOWS ARCHIV, 2019, 475 : S50 - S50
  • [24] Inconsistency associated with SOX11 immunohistochemistry in mantle cell lymphoma: a meta-analysis
    Woojoo Lee
    Eun Shin
    Bo Hyung Kim
    Hyunchul Kim
    Journal of Hematopathology, 2019, 12 : 109 - 119
  • [25] Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma
    He, Jianxia
    Xi, Yanfeng
    Gao, Ning
    Xu, Enwei
    Xie, Liwu
    Chang, Jin
    Liu, Jie
    JOURNAL OF BUON, 2019, 24 (04): : 1679 - 1685
  • [26] Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
    Nygren, Lina
    Wennerholm, Stefanie Baumgartner
    Klimkowska, Monika
    Christensson, Birger
    Kimby, Eva
    Sander, Birgitta
    BLOOD, 2012, 119 (18) : 4215 - 4223
  • [27] Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma
    He, J-X.
    Xi, Y-F.
    Su, L-P.
    Gao, N.
    Xu, E-W.
    Xie, L-W.
    Wang, L-Y.
    Zheng, Y-P.
    Han, W-E.
    Chang, J.
    Wang, H-W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (09) : 2556 - 2563
  • [28] Highly sensitive and specific in situ hybridization assay for quantification of SOX11 mRNA in mantle cell lymphoma reveals association of TP53 mutations with negative and low SOX11 expression
    Federmann, Birgit
    Frauenfeld, Leonie
    Pertsch, Helga
    Borgmann, Vanessa
    Steinhilber, Julia
    Bonzheim, Irina
    Fend, Falko
    Quintanilla-Martinez, Leticia
    HAEMATOLOGICA, 2020, 105 (03) : 754 - 764
  • [29] Differential expression of SOX4 and SOX11 in medulloblastoma
    Lee, CJ
    Appleby, VJ
    Orme, AT
    Chan, WI
    Scotting, PJ
    JOURNAL OF NEURO-ONCOLOGY, 2002, 57 (03) : 201 - 214
  • [30] Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma
    Vilarrasa-Blasi, Roser
    Verdaguer-Dot, Nuria
    Belver, Laura
    Soler-Vila, Paula
    Beekman, Renee
    Chapaprieta, Vicente
    Kulis, Marta
    Queiros, Ana C.
    Parra, Maribel
    Calasanz, Maria Jose
    Agirre, Xabier
    Prosper, Felipe
    Bea, Silvia
    Colomer, Dolors
    Marti-Renom, Marc A.
    Ferrando, Adolfo
    Campo, Elias
    Martin-Subero, Jose Ignacio
    LEUKEMIA, 2022, 36 (02) : 583 - 587
12345